Inactive Instrument
ARPIDA Stock Swiss Exchange
Stocks
ARPN
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| Nov. 02 | EvoNext Holdings Enters Deal to Merge with Ascend Sport Technology | MT |
| Oct. 12 | Ascend Sport Technology to List on SIX Swiss Exchange via EvoNext Merger | MT |
| Market Cap | 16.8M 20.48M 18.29M 15.26M 28.66M 1.94B 29.38M 201M 80.69M 1.02B 76.85M 75.21M 3.24B | P/E 2024 |
6.22x | P/E 2025 | -8.95x |
|---|---|---|---|---|---|
| Enterprise Value | 10.9M 13.28M 11.86M 9.9M 18.59M 1.26B 19.05M 130M 52.33M 664M 49.84M 48.78M 2.1B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
62.03% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Investor Relations Contact | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gianluca Ferrari
CHM | Chairman | - | 2025-03-26 |
Francesco Defila
BRD | Director/Board Member | - | 2025-03-26 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.04M 1.27M 1.14M 948K 1.78M 120M 1.82M 12.46M 5.01M 63.59M 4.77M 4.67M 202M | -653K -795K -711K -593K -1.11M -75.34M -1.14M -7.79M -3.13M -39.77M -2.99M -2.92M -126M |
| Net Debt | -6.75M -8.23M -7.35M -6.13M -11.52M -780M -11.81M -80.61M -32.43M -411M -30.89M -30.23M -1.3B | -5.91M -7.2M -6.43M -5.36M -10.07M -682M -10.33M -70.49M -28.36M -360M -27.01M -26.43M -1.14B |
Employees
-
- Stock Market
- Stocks
- EVE Stock
- ARPN Stock
Select your edition
All financial news and data tailored to specific country editions
















